POLE and neoplasm: A new signature, termed SBS-CRC1, was found in 17 tumours, all MSI or POLE mutant, and correlated with the defective DNA MMR SBS15 signature (r = 0.40, FDR-adjusted P = 7.82 × 10−40; Supplementary Table 14).